|

Medtronic SYMBIOSIS Post-Market Registry for Patients Undergoing Cardiac Surgery

RECRUITINGSponsored by Medtronic Cardiac Surgery
Actively Recruiting
SponsorMedtronic Cardiac Surgery
Started2020-01-09
Est. completion2026-12-31
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04241328

Summary

The purpose of this observational, multi-center prospective, post-market registry is to confirm real-world device safety and performance, to ensure the continued acceptability of identified risks, and detect emerging risks.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Subject or legally authorized representative provides written data release and/or informed consent per institution and/or geographical requirements prior to discharge from participating registry hospital.
* Subject will undergo or underwent a procedure in which an eligible Medtronic CS product is/was used.

Exclusion Criteria:

* Currently participating in an interventional drug or device study which may induce confounding factor(s) to the results from this Registry

Conditions2

Cardiovascular DiseasesHeart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.